D r. Anitha Rao delivered several presentations at the Alzheimer's Association International
Conference (AAIC) in London, UK, July 2017. [1] [2] [3] In an expert interview following AAIC 2017, Dr. Rao discusses the current limitations of standard care for patients with Alzheimer's disease and related dementias (ADRD), and puts into perspective the potential positive impact of important new technologies such as Neurocern.
Q. What are the major limitations of the current standard of care in patients with Alzheimer's disease and related dementias (ADRD)?
The shortage of behavioral neurologists and other cognitive specialists has impacted how patients and families access cognitive care for ADRD. According to American Academy of Neurology (AAN) membership data, in the US it is estimated that there are 600 geriatric or behavioral neurologists.
Current wait times to see a behavioral neurologist range from 3-6 months in some academic medical centers, representing a critical bottleneck for patients to access timely care. As a result of limited access to specialists, patients and families have been forced to turn to primary care and emergency rooms to manage complex neuro-behavioral symptoms.
Primary care and emergency room providers in many cases are not fully equipped to handle the symptoms, diagnosis, or to provide specialized care instructions to families. The New York Times recently published an article to highlight the need for education reform for ADRD and geriatrics among medical practitioners. 4 For most medical students, neurology is a 4th-year clerkship rotation that may not be part of their core curriculum. Many students decide medical specialties in their 3rd year, thereby missing the opportunity to explore a career path in neurology. In primary-care-focused residency programs such as Internal Medicine, neurology is often an optional elective, thereby further limiting exposure to geriatric care.
Q. How does the standard of care for ADRD vary across the US?
Researchers have demonstrated that specialists including geriatric and behavioral neurologists recognize and diagnose milder stages of dementia earlier than non-specialists. 5 An earlier diagnosis and access to specialists helps families find answers to their loved one's behavioral changes and reduces unnecessary and costly emergency room visits. In fact, a key study demonstrated patients diagnosed with ADRD by a specialist had lower Medicare costs in the year after diagnosis. 5 As many physicians recognize, ADRD is a complex clinical condition to manage as it requires a multidisciplinary clinic with social work and nursing support to help families navigate options in care. Yes, one of the most intriguing areas I have been focusing on is dementia co-existing with other chronic medical conditions. In fact, 95% of dementia patients have three or more chronic conditions. The costs of care are also much higher when patients have other chronic conditions such as diabetes and heart failure. For example, patients with diabetes and dementia see an 81% increase in medical costs compared with patients without dementia. 5 One of the main theories on why this substantial increase occurs is that these chronic conditions require self-management. When cognitive impairment is part of the clinical picture, it can seriously impact how well patients follow disease management instructions and access timely care.
It is important that other clinical specialties recognize the implications of cognitive impairment in their assessment and care plans for patients.
Q. How may new technologies like Neurocern be used in ADRD diagnosis and care planning?
Based on research from the AAN, projections show that the neurology workforce will continue to be significantly undermanned for years to come.
New technologies that provide clinical decision support will be extremely valuable for healthcare systems, primary care, and advanced practice providers in the diagnosis and care management of patients with dementia and other neurodegenerative diseases. For federally funded organizations such as the Area Agency of Aging, care planning tools will be key as the number of referrals will continue to grow.
In the international market, neurology supply is even lower than the US, and researchers recently reported that neurological disease is the number one cause of morbidity and mortality worldwide. 6 Neurologists will be in high demand and new technology like Neurocern offers us unique ways to reach more patients and dramatically improve care.
Q. Could you tell us a little about your journey as a technology entrepreneur?
Creativity has always been one of my strengths. In medical school, I chose to specialize in neurology because it gave me the freedom to be a creative physician for my patients. Whether it was finding new models of care for stroke, or using technology to help caregivers, neurology provided the perfect blend of imagination and science.
After medical school, I was drawn to pursue a career outside of traditional medicine and knew one day I'd like to work on large public health issues. 
